Marlin, Romain http://orcid.org/0000-0001-8932-0171
Desjardins, Delphine http://orcid.org/0000-0002-5820-3914
Contreras, Vanessa
Lingas, Guillaume
Solas, Caroline
Roques, Pierre http://orcid.org/0000-0003-1825-1054
Naninck, Thibaut http://orcid.org/0000-0002-6261-6412
Pascal, Quentin
Behillil, Sylvie
Maisonnasse, Pauline http://orcid.org/0000-0002-0555-207X
Lemaitre, Julien
Kahlaoui, Nidhal
Delache, Benoit
Pizzorno, Andrés http://orcid.org/0000-0002-0918-6804
Nougairede, Antoine http://orcid.org/0000-0001-7729-2636
Ludot, Camille
Terrier, Olivier http://orcid.org/0000-0001-9393-7684
Dereuddre-Bosquet, Nathalie http://orcid.org/0000-0001-6682-6313
Relouzat, Francis
Chapon, Catherine
Ho Tsong Fang, Raphael
van der Werf, Sylvie http://orcid.org/0000-0002-1148-4456
Rosa Calatrava, Manuel
Malvy, Denis
de Lamballerie, Xavier http://orcid.org/0000-0001-7895-2720
Guedj, Jeremie http://orcid.org/0000-0002-5534-5482
Le Grand, Roger http://orcid.org/0000-0002-4928-4484
Article History
Received: 17 March 2022
Accepted: 5 August 2022
First Online: 30 August 2022
Competing interests
: The funders had no role in study design, data collection, data analysis, data interpretation, or data reporting. The authors D.M., C.S., J.G., and X.d.L. report ongoing collaborations between their institution, INSERM, and Toyama, the manufacturer of Favipiravir. The remaining authors declare no competing interests.